FXH news

First Trust Health Care Alphadex Fund · Healthcare · United States

Stories about this fund's companies, ranked by fund weight and recency. Times are local.

Quartz · 28 Oct 2026, 12:37 UTC
10 Medicare Advantage insurer ratings for 2027 across 4 categories
6.9% of FXH
Quartz · 28 Oct 2026, 16:16 UTC
Best-selling drugs 2026: 7 of the top 10 by 2025 sales
5.4% of FXH
Quartz · 28 Oct 2026, 14:15 UTC
New weight-loss drugs: what 6 drugmakers are testing
4.2% of FXH
Benzinga · 28 Oct 2026, 19:32 UTC
Traders Are Pricing a 7% Swing in Amazon Ahead of Earnings - Amazon.com (NASDAQ:AMZN), Intel (NASDAQ:INTC
2.9% of FXH
Where to buy FXH
- [Broker A]Visit ↗
- [Broker B]Visit ↗
[Affiliate and risk wording from the law firm]
Seeking Alpha · 28 Oct 2026, 21:35 UTC
DaVita Q3 2026 Earnings Preview (NYSE:DVA) | Seeking Alpha
2.2% of FXH
Seeking Alpha · 28 Oct 2026, 20:02 UTC
Biogen anticipates $250M of run rate synergies by end of 2027 as it raises 2026 non-GAAP EPS to $12.20-$13 (NASDAQ:BIIB) | Seeking Alpha
2.2% of FXH
Where to buy FXH
- [Broker A]Visit ↗
- [Broker B]Visit ↗
[Affiliate and risk wording from the law firm]
Seeking Alpha · 28 Oct 2026, 20:00 UTC
Biogen Inc. (BIIB) Q3 2026 Earnings Call Transcript | Seeking Alpha
2.2% of FXH
Seeking Alpha · 28 Oct 2026, 15:55 UTC
Pharma giants Merck, Eli Lilly face earnings health check (MRK:NYSE) | Seeking Alpha
2.5% of FXH
Seeking Alpha · 28 Oct 2026, 19:01 UTC
Biogen Inc. 2026 Q3 - Results - Earnings Call Presentation (NASDAQ:BIIB) 2026-10-28 | Seeking Alpha
2.2% of FXH
Seeking Alpha · 28 Oct 2026, 14:11 UTC
The Cigna Group: Client Retention Matters, But Contract Profitability Matters More | Seeking Alpha
2.4% of FXH
24/7 Wall St. · 28 Oct 2026, 12:14 UTC
3 Big Pharma Earnings Reports to Watch: Eli Lilly, Merck and Gilead
2.5% of FXH
Investing.com · 28 Oct 2026, 15:42 UTC
Incyte earnings up next: Analysts eye loss amid pipeline gains By Investing.com
2.2% of FXH
Market Screener · 28 Oct 2026, 14:41 UTC
Adagene Inc. Announces Dosing of First Patient in Phase 1 Study of Muzastotug in Combination with Incyte?S Inca33890 in Patients with Microsatellite Stable Colorectal Cancer
2.2% of FXH
Investing.com · 28 Oct 2026, 13:52 UTC
Earnings call transcript: Biogen beats Q3 2026 estimates as growth portfolio expands By Investing.com
2.2% of FXH
Investing.com · 28 Oct 2026, 13:42 UTC
Exelixis stock hits all-time high at 65.62 USD By Investing.com
2.2% of FXH
Seeking Alpha · 28 Oct 2026, 16:40 UTC
Universal Health Services, Inc. (UHS) Q3 2026 Earnings Call Transcript | Seeking Alpha
2.0% of FXH
24/7 Wall St. · 28 Oct 2026, 20:26 UTC
Encompass Health beats Q3 2026 estimates for the eighth straight quarter
1.8% of FXH
The Wall Street Journal · 28 Oct 2026, 11:09 UTC
Biogen Swings to Loss, Logs Higher Sales
2.2% of FXH
Seeking Alpha · 28 Oct 2026, 11:04 UTC
Biogen posts Q3 beat on multiple sclerosis drugs (BIIB:NASDAQ) | Seeking Alpha
2.2% of FXH
The Manila times · 28 Oct 2026, 11:11 UTC
Adagene Announces Dosing of First Patient in Phase 1 Study of Muzastotug in Combination with Incyte's INCA33890 in Patients with Microsatellite Stable Colorectal Cancer
2.2% of FXH

FXH news

Where to buy FXH

Where to buy FXH